Helping Pharma Industry with Digital, Data and Analytics with our value-based services
We help leading pharmaceutical, MEDtech and biotech companies transform Commercial and Medical Affairs functions with our end-to-end digital, data, and analytics services.
With tailored consulting, managed services, and digital transformation expertise, we drive evidence-based decision-making, global-to-local alignment, and measurable business and scientific impact. Our capabilities enable companies to anticipate market dynamics, shape strategic decision-making, and demonstrate scientific and commercial value across the product life cycle.
Commercial Services
Sales leaders & IT teams need to upgrade or optimize legacy CRM systems.
Faster go-live, higher adoption, cleaner data, and improved field productivity.
Commercial leaders & field teams need real-time visibility into HCP engagement and performance.
Smarter resource allocation, stronger HCP relationships, and data-driven insights.
Sales reps & MSL managers want to personalize HCP interactions and improve engagement quality.
Targeted outreach, optimized channel mix, and higher ROI from Commercial activities.
Market Access & KAM teams face challenges with payer access and account-level strategy.
Accelerate patient access, Optimized Account Strategy, Strategic Insights for Decision-Making
Medical Affairs Services
Your Medical Affairs processes are fragmented and inconsistent.
Global-to-local misalignment? Teams struggle to adapt a consistent strategy worldwide, causing duplication, delays, and wasted resources.
Improved decision Making
Start trials sooner. Launch studies earlier, increase patient enrollment, and accelerate time-to-market.
Real-time tracking of evidence needs and portfolio progress across all IEPs.
Delays piling up?Clinical and R&D teams can’t always identify which studies to start early to stay ahead of competitors.
Maximize ROI by prioritizing high-impact studies and eliminating redundancies.
Enhance strategic visibility with a centralized, real-time evidence catalog.
Reduce risk through integrated study tracking and proactive portfolio oversight.
One unified plan. Align Medical, Commercial, HEOR, and Access teams with a single cross- functional communication strategy.
Tailored narratives and measurable scientific impact
Better governance. Ensure consistent internal and external messaging across the product lifecycle—pre-launch, launch, and sustain.
Inconsistent messaging slowing you down? Teams struggle to align scientific and brand narratives across functions, regions, and product phases.
Disconnected planning? Publications, abstracts, and congress deliverables often operate in silos, leading to duplication and missed opportunities.
Difficulty coordinating KOL engagements? Medical Affairs teams often face overlapping schedules, inconsistent messaging, and missed opportunities to build deeper relationships.
Lost strategic insights? Valuable intelligence—Beliefs, Behaviors Ideas, and Thoughts —from KOL discussions often goes undocumented or remains siloed.
Centralized planning and coordination
Stronger cross-functional alignment
Actionable intelligence: AI filters noise and delivers insights
Monitor HCP, patient, and competitor conversations & sentiment pre-peri and post congresses
Limited visibility across teams? Without a centralized approach, it’s hard to track deliverables, align cross-functional stakeholders, or measure impact.
Too much noise, not enough insights? Teams struggle to cut through the volume of online chatter to find meaningful intelligence.
Missing the real-time pulse? Key HCP and competitor conversations at congresses often go unnoticed without dedicated social listening. "You’re unsure how HCPs and the market perceive your science." Medical Affairs teams need sentiment intelligence.
Early detection of shifting HCP sentiment
Accelerate the uptake of new data and therapies.
Detect negative sentiment, competitor activity, and unmet needs from key social media platforms
Refine brand positioning, accelerate evidence adoption, and improve market impact.
Unsure who really drives the conversation? It’s challenging to pinpoint the high-impact HCPs, advocacy voices, and emerging digital opinion leaders shaping opinions online.
Missing real-time signals at major events? Negative sentiment, data gaps, or unmet needs often go undetected during congresses, drug launches, data releases, leading to missed opportunities for intervention.
No clear map of influence? Without understanding HCP networks and referral patterns, it’s difficult to identify clusters of influence or optimize engagement strategies.
